Article
Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine…
medRxiv · 2021 · Marcus, R. K.; Ferri-Borgogno, S.; Hosein, A.; Foo, W. C.; Ghosh, B.; Zhao, J.; Rajapakshe, K.; Brugarolas, J.; Maitra, A.; Gupta, S.
Key facts
| Title | Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma |
|---|---|
| First author | Marcus, R. K.; Ferri-Borgogno, S.; Hosein, A.; Foo, W. C.; Ghosh, B.; Zhao, J.; Rajapakshe, K.; Brugarolas, J.; Maitra, A.; Gupta, S. |
| Journal | medRxiv |
| Published | Oct 13, 2021 |
| DOI | 10.1101/2021.10.12.464103 |
| Devices mentioned | 016832 |
| Product codes mentioned | JJH, NSU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1